Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | ADH1B | P00325 | 1/20 | 0.39 |
| ▸ | ADH1C | P00326 | 1/20 | 0.39 |
| ▸ | ADH1A | P07327 | 1/20 | 0.39 |
| ▸ | ADH4 | P08319 | 1/20 | 0.39 |
| ▸ | ADH7 | P40394 | 1/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15638673 | 1.00 | TSHR (0.48) | TSHROPRM1SPHK1LMNADNM1 | |
| SCHEMBL31338794 | 1.00 | TSHR (0.48) | TSHROPRM1SPHK1LMNADNM1 | |
| SCHEMBL28695900 | 1.00 | TSHR (0.48) | TSHROPRM1SPHK1LMNADNM1 | |
| SCHEMBL5495726 | 1.00 | TSHR (0.48) | TSHROPRM1SPHK1LMNADNM1 | |
| SCHEMBL196200 | 1.00 | TSHR (0.48) | TSHROPRM1SPHK1LMNADNM1 | |
| SCHEMBL25252646 | 1.00 | TSHR (0.48) | TSHROPRM1SPHK1LMNADNM1 | |
| SCHEMBL9787863 | 1.00 | TSHR (0.48) | TSHROPRM1SPHK1LMNADNM1 | |
| SCHEMBL20725833 | 1.00 | TSHR (0.48) | TSHROPRM1SPHK1LMNADNM1 | |
| SCHEMBL22263515 | 1.00 | TSHR (0.48) | TSHROPRM1SPHK1LMNADNM1 | |
| SCHEMBL27697767 | 1.00 | TSHR (0.48) | TSHROPRM1SPHK1LMNADNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 377 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024017178-A1 | SUBSTITUTED HYDANTOIN COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | AVITAR BIOSCIENCES, INC. (CN) | 2024-01-25 | — | — | WO | claimed |
| EP-4074807-B1 | COMPOSITIONS COMPRISING A FLUOROOLEFIN | CHEMOURS CO FC LLC (US) | 2025-07-09 | — | — | EP | disclosed |
| EP-3543310-B2 | COMPOSITIONS COMPRISING HFC-1234YF AND HFC-32 | CHEMOURS CO FC LLC (US) | 2024-07-03 | — | — | EP | disclosed |
| EP-3299435-B1 | METHOD OF PREPARING A COMPOSITION COMPRISING HFC-1234YF | CHEMOURS CO FC LLC (US) | 2024-06-26 | — | — | EP | disclosed |
| CN-115605480-B | Sulfonylamide-substituted compounds and their use as beta-lactamase inhibitors | 宁夏农林科学院 | 2024-04-05 | — | — | CN | disclosed |
| CN-117683029-A | Bcl-2 inhibitors | 百济神州有限公司 | 2024-03-12 | — | — | CN | disclosed |
| EP-3309233-B2 | COMPOSITIONS COMPRISING HFC-1234YF AND HFC-152A | CHEMOURS CO FC LLC (US) | 2024-02-21 | — | — | EP | disclosed |
| EP-2749623-B2 | Method for replacing a high GWP refrigerant in a refrigeration, air-conditioning, or heat pump apparatus | CHEMOURS CO FC LLC (US) | 2024-02-21 | — | — | EP | disclosed |
| CN-113845884-B | Compositions comprising fluoroolefins | 科慕埃弗西有限公司 | 2024-02-02 | — | — | CN | disclosed |
| WO-2024017178-A1 | SUBSTITUTED HYDANTOIN COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | AVITAR BIOSCIENCES, INC. (CN) | 2024-01-25 | — | — | WO | disclosed |
| WO-2002046328-A2 | REFRIGERANT COMPOSITIONS CONTAINING A COMPATIBILIZER | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2002-06-13 | — | — | WO | disclosed |
| EP-1171416-A1 | 3-BICYCLOARYL-2-AMINOMETHYL BICYCLOALKANES AS SEROTONINE REUPTAKE INHIBITORS | ELI LILLY AND COMPANY LIMITED (GB) | 2002-01-16 | — | — | EP | disclosed |
| WO-2000061539-A1 | 3-BICYCLOARYL-2-AMINOMETHYL BICYCLOALKANES AS SEROTONINE REUPTAKE INHIBITORS | ELI LILLY AND COMPANY LIMITED (GB) | 2000-10-19 | — | — | WO | disclosed |
| EP-0792259-B1 | CATALYZED VAPOR PHASE HYDROCYANATION OF DIOLEFINIC COMPOUNDS | DU PONT (US) | 1999-08-04 | — | — | EP | disclosed |
| EP-0792259-A1 | CATALYZED VAPOR PHASE HYDROCYANATION OF DIOLEFINIC COMPOUNDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-09-03 | — | — | EP | disclosed |
| WO-1996016022-A1 | CATALYZED VAPOR PHASE HYDROCYANATION OF DIOLEFINIC COMPOUNDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-05-30 | — | — | WO | disclosed |
| US-5449807-A | Using complex of zero-valent nickel and bidentate phosphate ligand as catalyst | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-09-12 | — | — | US | disclosed |
| EP-0267136-B1 | QUATERNARY AMMONIUM SALTS USED AS PHASE TRANSFER CATALYSTS | ALTER, S.A. (ES) | 1990-09-19 | — | — | EP | disclosed |
| EP-0267136-A2 | Quaternary ammonium salts used as phase transfer catalysts | ALTER, S.A. (ES) | 1988-05-11 | — | — | EP | disclosed |
| US-4098806-A | PROCESS FOR FUNCTIONALIZING PERFLUOROHALOGENOALKANES | PRODUITS CHIMIQUES UGINE KUHLMANN (FR) | 1978-07-04 | — | — | US | disclosed |